April 3, 2023
On March 9, Shimadzu Corporation (Kyoto, hereinafter Shimadzu), Kyushu University (Fukuoka), and Kazusa DNA Research Institute (Kisarazu, Chiba Prefecture) opened the Auto Biomolecular analysis Systematization Laboratory (ABiS Lab.) on the first floor of the Healthcare R&D Center, a research and development building at the Shimadzu Head Office. This lab will be a center for collaborative [...]
Evident Acquired by Bain Capital: Partnership to Accelerate Future Growth and Innovation
April 3, 2023
TOKYO — Evident Corporation (“Evident”) announced today that it has been acquired by private equity firm Bain Capital Private Equity (“Bain Capital”) from Olympus Corporation (“Olympus”) pursuant to the definitive agreement signed on August 29, 2022. Evident was newly established on April 1, 2022 as a wholly owned subsidiary of Olympus comprising the former Scientific [...]
April 3, 2023
CrestOptics launches CICERO system to provide all-in-one solution for widefield and spinning disk confocal microscopy System launched at Focus on Microscopy (FOM) conference 2nd – 5th April, Porto, Portugal Rome, IT: CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications, today announced the launch of its new spinning disk confocal microscope system, CICERO. [...]
Limerston Capital acquires Concept Life Sciences
April 3, 2023
New leadership team, led by Dr Ben Cliff, will drive growth in pharmaceutical development and discovery & biologics Limerston Capital LLP (Limerston Capital) has announced the acquisition of Concept Life Sciences, a leading integrated drug discovery, development and manufacturing organisation, in a carve-out from Spectris plc. The deal will see Concept Life Sciences cement its [...]
BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
April 3, 2023
MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its investment in Wilson Wolf Manufacturing. Wilson Wolf achieved the trailing 12-month earnings before interest, taxes, depreciation, and amortization (EBITDA) target of $55 million, triggering Bio-Techne's initial investment in the company. Bio-Techne's $257 million investment gives the Company a 20% ownership stake in Wilson [...]
April 3, 2023
SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today announced that it will appeal the Federal Trade Commission's ("FTC") decision ordering the unwinding of Illumina's acquisition of GRAIL. Illumina intends to file a petition for review promptly with a US Court of Appeals and will seek expedited treatment of the appeal. The FTC's order to unwind the [...]
Hanna Instruments, Inc. Announces New Advanced Benchtop Meter Series
March 31, 2023
Smithfield, RI – Hanna Instruments, Inc. (Hanna) announces its new Advanced Benchtop Meter Series. There are three new models available with one benchtop meter for testing pH, another dedicated to Conductivity, and lastly, there is one for measuring Dissolved Oxygen. Providing fast, accurate, and repeatable measurements, Hanna’s New Advanced Benchtop Meters are perfect for various [...]
Eppendorf adds digital documentation to connected electronic pipette system
March 31, 2023
Hamburg -- The Pipette Manager serves as a wireless control panel for Eppendorf's connected electronic pipettes, adding new features and revolutionizing the speed and reproducibility of handheld pipetting. With this innovative system, scientists can easily adjust connected pipette modes, settings, and volumes via a large touch display. The system's Liquid Manager feature offers predefined pipette [...]
Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up
March 31, 2023
New Releases Extend the BioXp® Select Product Line, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Synthetic Biology Workstation SAN DIEGO -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced continued expansion of the BioXp® Select Kit product line, releasing two novel kits to [...]
Sartorius Stedim Biotech to acquire Polyplus
March 31, 2023
France-based Polyplus is a provider of innovative upstream technologies for cell and gene therapies Polyplus' transfection reagents and plasmids are key components in the manufacturing of viral vectors Agreed purchase price of approximately 2.4 billion euros Aubagne -- Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has signed an agreement to [...]

